Cargando…
Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512043/ https://www.ncbi.nlm.nih.gov/pubmed/36797011 http://dx.doi.org/10.1136/svn-2023-002321 |
| _version_ | 1785108277440282624 |
|---|---|
| author | Wang, David Leo, Christopher Liu, Liping Huang, Li Huang, Lisa Lu, Yun |
| author_facet | Wang, David Leo, Christopher Liu, Liping Huang, Li Huang, Lisa Lu, Yun |
| author_sort | Wang, David |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10512043 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105120432023-09-22 Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy Wang, David Leo, Christopher Liu, Liping Huang, Li Huang, Lisa Lu, Yun Stroke Vasc Neurol Editorial BMJ Publishing Group 2023-02-16 /pmc/articles/PMC10512043/ /pubmed/36797011 http://dx.doi.org/10.1136/svn-2023-002321 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Editorial Wang, David Leo, Christopher Liu, Liping Huang, Li Huang, Lisa Lu, Yun Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy |
| title | Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy |
| title_full | Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy |
| title_fullStr | Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy |
| title_full_unstemmed | Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy |
| title_short | Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy |
| title_sort | antithrombotic therapy in patients with covid-19: indications, pharmacotherapy and controversy |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512043/ https://www.ncbi.nlm.nih.gov/pubmed/36797011 http://dx.doi.org/10.1136/svn-2023-002321 |
| work_keys_str_mv | AT wangdavid antithrombotictherapyinpatientswithcovid19indicationspharmacotherapyandcontroversy AT leochristopher antithrombotictherapyinpatientswithcovid19indicationspharmacotherapyandcontroversy AT liuliping antithrombotictherapyinpatientswithcovid19indicationspharmacotherapyandcontroversy AT huangli antithrombotictherapyinpatientswithcovid19indicationspharmacotherapyandcontroversy AT huanglisa antithrombotictherapyinpatientswithcovid19indicationspharmacotherapyandcontroversy AT luyun antithrombotictherapyinpatientswithcovid19indicationspharmacotherapyandcontroversy |